Replies to post #184513 on Biotech Values

[DewDiligence]

XOMA—While I would agree that the financing terms are not bad, using warrants in any form can be construed as a sign of weakness. In these kinds of offerings, some buyers typically sell the stock quickly and keep the warrants.